As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles,
Do Weight Loss Drugs Lead to Grocery Sales Losses?
According to that study, those who use GLP-1 dugs, such as Wegovy and Ozempic, cut their grocery spend by about 6% during the first few months after starting their prescription, translating to $416 annually. The impact is even greater in higher-income households earning over $125,000, who reduce their grocery spending by 9%, or $690, annually.
By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers found. Common adverse side effects from the drugs included nausea, vomiting, ...
Weight loss can be a challenge for many, and with advances in medication, new options are available to help those struggling ...
As 2025 ushers in a new era of weight loss resolutions, many Americans are abandoning traditional gym-first approaches in ...
While GLP-1 medications like Ozempic and Wegovy ... remain manageable Insurance coverage continues expanding New ...
In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...
The hype and demand of the new weight-loss medications have shifted not only how health care approaches weight loss, but also (and more importantly) the risk of obesity-related ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback